Local Firms Leery of Committing to SARS Research
Biotech: Long-Term Need For Virus Treatment Raises Questions About Investment

BY MARION WEBB

The SARS public-health crisis has led a few local biotechnology companies to set up some of the first programs to investigate the disease...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129